The U.S. Food and Drug Administration's reviewers on Wednesday raised efficacy concerns over the use of Otsuka Pharma's drug ...

A new study has found that military veterans who attended retreats involving psychedelic substances like psilocybin or ...

An FDA advisory panel will meet July 18 to consider a supplemental new drug application for the antipsychotic brexpiprazole, ...

Kodiak Harbormaster and Borough Assemblyman Dave Johnson is back on the job after spending the past six weeks in therapy for ...

A woman said she felt "robbed" of her birth experience after a "painful" and "traumatic" delivery left her with ...

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to TSND-201 (methylone) for the treatment of posttraumatic stress disorder (PTSD).

The tool can help overcome barriers to diagnosis, like cognitive development, language skills, avoidance behaviors and ...

A new study found active-duty service members with sleep apnea face a greater risk of PTSD or a traumatic brain injury, ...

Edmondson has been the lead investigator on or participated on research teams behind more than 50 clinical studies showing ...

The U.S. Food and Drug Administration's staff reviewers on Wednesday raised efficacy concerns over Otsuka Pharma's combination treatment for adults with post-traumatic stress disorder (PTSD), citing ...